| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 15.173 | 0 | 0 | 0 | 10.899 | 116.435 |
| Total Income - EUR | - | - | 0 | 0 | 16.370 | 1.987 | 11.876 | 6.060 | 16.918 | 121.842 |
| Total Expenses - EUR | - | - | 0 | 0 | 3.220 | 442 | 6.304 | 2.881 | 3.640 | 15.333 |
| Gross Profit/Loss - EUR | - | - | 0 | 0 | 13.150 | 1.546 | 5.571 | 3.179 | 13.279 | 106.509 |
| Net Profit/Loss - EUR | - | - | 0 | 0 | 12.695 | 1.546 | 5.571 | 3.179 | 13.170 | 104.445 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Afin New Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 876 | 860 | 2.234 | 2.191 | 0 | 3.030 | 4.012 | 3.990 |
| Current Assets | - | - | 12 | 12 | 10.071 | 10.979 | 18.450 | 18.655 | 20.690 | 66.199 |
| Inventories | - | - | 0 | 0 | 7.856 | 7.707 | 11.638 | 14.244 | 17.211 | 17.396 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 2.863 | 28.725 |
| Cash | - | - | 12 | 12 | 2.215 | 3.272 | 6.811 | 4.411 | 617 | 20.078 |
| Shareholders Funds | - | - | 44 | 43 | 12.737 | 14.041 | 19.301 | 22.539 | 22.362 | 48.279 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.956 | 1.920 | 638 | 179 | 176 | 176 | 3.368 | 22.931 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "125 - 125" | |||||||||
| CAEN Financial Year |
125
|
|||||||||
Comments - Afin New Bio Srl